1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Key Pharma News 19 JANUARY 2015

Key Pharma News 19 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 34 pages

Industry Trend Analysis - Payer Pressure Forces Gilead/AbbVie Drug Pricing Battle To Remain Heated
Industry Trend Analysis - Investment In Alzheimer's R&D To Continue With Focus On Mild Disease
Industry Brief - Vanda To Regain US/Canadian Rights To Fanapt
Industry Brief - Amgen/Kite Collaborate To Develop CAR T-Cell Immunotherapies
Industry Brief - Vectura/Janssen Sign Deal To Develop Anti-Inflammatory Therapy
Industry Brief - KHK/Syndax Sign Deal To Develop Entinostat In Japan/Korea
Industry Brief - Otsuka Reports Termination Of Contracts With OTS/Fuso Pharmaceutical Industries
Industry Brief - Seattle Genetics/BMS Enter Clinical Trial Collaboration For Adcetris/Opdivo
Industry Brief - Mersana/Takeda Expand Fleximer-ADC Collaboration
Industry Trend Analysis - Incyte/Agenus Collaboration Raises Profile In Immuno-Oncology Market
Industry Brief - MedImmune/Omnis Sign Licensing Deal For Oncolytic Viruses In Immuno-Oncology
Industry Brief - Merck/Lilly Enter Collaboration For Keytruda Combination Regimens
Industry Trend Analysis - Expanded Portfolio Will Help Biogen Idec Sustain Growth
Industry Brief - Cardio3 Enters Immuno-Oncology Space With OnCyte Acquisition
Industry Brief - Shire To Acquire NPS Pharma
Industry Brief - Otsuka Completes Avanir Acquisition
Industry Brief - Tekmira/OnCore Merge To Create Global HBV Company
Industry Trend Analysis - Roche's Majority Stake In Foundation Medicine Will Bolster NGS Oncology Efforts
Industry Trend Analysis - High NME FDA Approvals In 2014 Indicates New Era For Anti-Infectives
Industry Brief - Daiichi Sankyo Pays USD39mn To Settle Kickback Allegations
Industry Trend Analysis - Incentives Will Continue To Generate Interest In Orphan Diseases
Industry Trend Analysis - Resubmitted Cariprazine Can Expect Slow Sales Growth
Industry Trend Analysis - US HCV Drug Pricing Battle To Extend To Europe
Industry Brief - FDA Approves Rytary For PD
Industry Trend Analysis - South African ARV Tender Will Increase Rewards And Pressure On Generic Firms
Industry Brief - Mundipharma Receives Positive EC Decision On Targin For RLS
Industry Brief - Praluent MAA Accepted For Review By EMA
Industry Brief - Health Canada Approves Novartis' Fluad Pediatric Flu Vaccine
Industry Brief - Gilead/CVS Team Up For HCV Drugs
Industry Trend Analysis - US Approval Of Sandoz' Filgrastim Advances With Small Steps, Not Giant Leaps
Industry Brief - FDA Approves AbbVie's Duopa For Motor Fluctuations In Advanced PD Patients
Industry Brief - Chipscreen Receives Chinese Approval For Epidaza In PTCL
Industry Brief - FDA Approves Savaysa For NVAF/VTE
Industry Trend Analysis - Colchicine Marketing Battle To Re-Emerge In US
Industry Brief - Health Canada Approves Actemra For Early RA
Industry Trend Analysis - UK Political Parties Provide Limited Options For A Sustainable Cancer Drugs Fund
Industry Trend Analysis - Gilead Likely To Weather The Indian Sofosbuvir Patent Rejection Storm
Industry Trend Analysis - Keytruda/Opdivo Competition To Intensify
Industry Brief - Perampanel Phase III Trial Conducted In Asia Meets Primary Endpoint
Industry Brief - Positive Results Reported From First Phase III Trials Of Alirocumab
Industry Brief - Phase II/III And III Trials Of Rasagiline For PD Start In Japan
Industry Brief - First Of Three Sativex Phase III Cancer Pain Trials Misses Primary Endpoint
Industry Brief - Cempra Announces Positive Top-Line Phase III Results For Oral Solithromycin In CABP
Industry Trend Analysis - SABCS Highlights Focus On HER2- And PD-1-Targeting Drugs For BC
Industry Brief - Nivolumab Receives PMI Status For Advanced Melanoma

Table Of Contents

Key Pharma News 19 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.